[Journal logo]

Volume 67 
Part 10 
Page o2690  
October 2011  

Received 11 September 2011
Accepted 15 September 2011
Online 20 September 2011

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.003 Å
R = 0.043
wR = 0.125
Data-to-parameter ratio = 24.8
Details
Open access

(Z)-Methyl 2-[(4-bromo-2-formylphenoxy)methyl]-3-o-tolylacrylate

aDepartment of Physics, Sri Balaji Chokkalingam Engineering College, Arni, Thiruvannamalai 632 317, India,bDepartment of Physics, Ranipettai Engineering College, Thenkadapathangal, Walaja 632 513, India,cDepartment of Physics, Thanthai Periyar Government Institute of Technology, Vellore 632 002, India, and dDepartment of Organic Chemistry, University of Madras, Maraimalai Campus, Chennai 600 025, India
Correspondence e-mail: smurugavel27@gmail.com

In the title compound, C19H17BrO4, the dihedral angle between the two benzene rings is 82.1 (1)°. The molecular structure is stabilized by an intramolecular C-H...O hydrogen bond which generates an S(7) ring motif. The crystal packing is stabilized by intermolecular C-H...O hydrogen bonds and C-H...[pi] interactions. Intermolecular C-H...O interactions are involved in the formation of centrosymmetric R22(16) dimers, which are connected into supramolecular tapes running along the [100] direction.

Related literature

For background to the applications of acrylates, see: de Fraine et al. (1991[Fraine, P. J. de & Martin, A. (1991). US Patent 5 055 471.]); Zhang & Ji (1992[Zhang, L. P. & Ji, Z. Z. (1992). Acta Pharmacol. Sin. 27, 817-823.]). For related structures, see: Wang et al. (2011[Wang, L., Meng, F.-Y., Lin, C.-W., Chen, H.-Y. & Luo, X. (2011). Acta Cryst. E67, o354.]); Hou (2008[Hou, J. (2008). Acta Cryst. E64, o2293.]). For hydrogen-bond motifs, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]).

[Scheme 1]

Experimental

Crystal data
  • C19H17BrO4

  • Mr = 389.24

  • Triclinic, [P \overline 1]

  • a = 8.0114 (2) Å

  • b = 8.6138 (2) Å

  • c = 13.4827 (4) Å

  • [alpha] = 96.466 (1)°

  • [beta] = 97.185 (1)°

  • [gamma] = 106.546 (2)°

  • V = 874.08 (4) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 2.37 mm-1

  • T = 293 K

  • 0.25 × 0.23 × 0.18 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 1996[Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.]) Tmin = 0.547, Tmax = 0.653

  • 21788 measured reflections

  • 5440 independent reflections

  • 2870 reflections with I > 2[sigma](I)

  • Rint = 0.025

Refinement
  • R[F2 > 2[sigma](F2)] = 0.043

  • wR(F2) = 0.125

  • S = 1.02

  • 5440 reflections

  • 219 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.61 e Å-3

  • [Delta][rho]min = -0.61 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg is the centroid of the C13-C18 benzene ring.

D-H...A D-H H...A D...A D-H...A
C14-H14...O3 0.93 2.59 3.377 (3) 143
C19-H19B...O1i 0.96 2.53 3.436 (3) 157
C5-H5...O4ii 0.93 2.44 3.273 (3) 149
C19-H19C...Cgiii 0.96 2.74 3.580 (3) 147
Symmetry codes: (i) -x+1, -y, -z; (ii) x+1, y, z; (iii) -x+2, -y+1, -z.

Data collection: APEX2 (Bruker, 2004[Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: APEX2 and SAINT (Bruker, 2004[Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT and XPREP (Bruker, 2004[Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BT5640 ).


Acknowledgements

SM thanks Dr Babu Vargheese, SAIF, IIT, Madras, India, for his help with the data collection.

References

Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.  [CrossRef] [ChemPort] [ISI]
Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Fraine, P. J. de & Martin, A. (1991). US Patent 5 055 471.
Hou, J. (2008). Acta Cryst. E64, o2293.  [CrossRef] [details]
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Wang, L., Meng, F.-Y., Lin, C.-W., Chen, H.-Y. & Luo, X. (2011). Acta Cryst. E67, o354.  [CSD] [CrossRef] [details]
Zhang, L. P. & Ji, Z. Z. (1992). Acta Pharmacol. Sin. 27, 817-823.  [ChemPort]


Acta Cryst (2011). E67, o2690  [ doi:10.1107/S1600536811037731 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.